Tracey O’Brien: Harnessing digital health for enhanced cancer research and patient outcomes

Tracey O’Brien shared a post by  NSW Regional Cancer Research Network on LinkedIn, adding:

“With support from the Cancer Institute NSW, the 3 large NSW translational cancer research networks come together to host the NSW Cancer Research Education Statewide Seminar Series. It’s a great forum for enhancing collaboration and knowledge sharing.

There are over 2000 clinicians, researchers, and consumers working together across the translational research networks, contributing to driving better cancer and health outcomes. Register for the next online forum and hear from Rebecca Wyse and Dr Anna Singleton on harnessing digital health for enhanced cancer research and patient outcomes.”

Quoting  NSW Regional Cancer Research Network‘s post:

“You are invited to join the NSW Regional Cancer Research Network, Sydney Partnership for Health, Education, Research and Enterprise (SPHERE)-Cancer CAG and Sydney Health Partners -Cancer CAG for the next NSW Cancer Research Education Statewide Seminar.

Topic: Harnessing Digital Health for Enhanced Cancer Research and Patient Outcomes

Date: Tuesday, September 17th
Time: 12:30 PM – 1:30 PM
Format: Online Teams Seminar
Register.

Associate professor Rebecca Wyse and Dr. Anna Singleton will present on how digital health technologies offer transformative potential for cancer care through platforms like telemedicine, real-time patient monitoring, and data-driven decision-making. This seminar will showcase how integrating digital health tools can transform patient experiences, making cancer care more accessible and effective.

Speakers:

Associate professor Rebecca Wyse – Cancer Institute NSW Early Career Research Fellow, University of Newcastle. Rebecca’s behavioural research is helping to support the primary and secondary prevention of chronic disease and support preparation for the recovery from surgery.

She designs, delivers and evaluates digital interventions with wide reach. Her current work is focused on supporting cancer patients prepare for and recover from surgery, where she has led the development of the ‘RecoverEsupport’ intervention series, which will be trialed in two randomised controlled trials with patients from the John Hunter Hospital, Newcastle Private Hospital and Calvary Mater Hospital.

Dr Anna Singleton – NHMRC Emerging Leadership Fellow & Senior Research Fellow, University of Sydney. Anna’s research aims to use scalable and accessible digital health strategies to improve health outcomes for people living with and beyond cancer. Anna’s EMPOWER-SMS clinical trial won the 2022 Consumer Involvement Award at the Australian Clinical Trials Alliance Trial of the Year Awards.

This trial found that a health and wellness support program delivered via text messages was acceptable, useful and engaging for breast cancer survivors. Anna holds many leadership positions, including the co-chair of the Primary Care Collaborative Cancer Clinical Trials group Survivorship Engine Room and Topic Editor of Frontiers in Digital Health.

Chair:
Dr Allison Boyes, Senior Research Academic, and NSWRCRN Senior Research and Engagement Partner. Allison is a behavioural scientist who holds a PhD in Behavioural Science and has received Early Career Research Fellowships from the NHMRC (2014-2020) and Cancer Institute NSW (2014-2018). With a background in psychology and public health, her research focuses on improving the wellbeing of individuals affected by chronic diseases, particularly in the areas of cancer, dementia, and mental health.

Register now to reserve your spot! ”

Source: Tracey O’Brien/LinkedIn and NSW Regional Cancer Research Network/LinkedIn

More posts featuring Tracey O’Brien on oncodaily.com

Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program.

Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group.

In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology. In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category.

In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University).

Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.

Rebecca Wyse is a research fellow at The University of Newcastle. She is the Heart Foundation Future Leader Fellow (Honorary) at The University of Newcastle. Previously she was a NHMRC TRIP Fellow at The University of Newcastle.

Anna Singleton is Senior Research Fellow & NHMRC Emerging Leadership Fellow at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council New South Wales (NSW). She also co-chairs the Primary Care Collaborative Cancer Clinical Trials group’s Living With and Beyond Cancer Engine Room. She has served as a research assistant at The George Institute for Global Health.